Related references
Note: Only part of the references are listed.Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008
Moran G. Goren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany
C. Wendt et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Ertapenem-Resistant Enterobacteriaceae: Risk Factors for Acquisition and Outcomes
E. P. Hyle et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes
Eleni Mouloudi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study
Olympia Zarkotou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Worldwide Diversity of Klebsiella pneumoniae That Produces β-Lactamase blaKPC-2 Gene
Gaelle Cuzon et al.
EMERGING INFECTIOUS DISEASES (2010)
Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns
Khetam Hussein et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa
Nimish Patel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients
Min-Hyok Jeon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points
Kerri A. Thom et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Use of different thresholds of prior antimicrobial use in defining exposure: Impact on the association between antimicrobial use and antimicrobial resistance
Emily P. Hyle et al.
JOURNAL OF INFECTION (2007)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates
Thomas P. Lodise et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections
Jessina C. McGregor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection
S Bratu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Impact of severity of illness bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms
AD Harris et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York
S Bratu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
In vitro activity of ertapenem:: review of recent studies
HM Wexler
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001
JA Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Control-group selection importance in studies of antimicrobial resistance:: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli
AD Harris et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
